Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/24
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 06/01/24
End: 06/01/25
Due: 06/01/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19 | NCT05996770 | Xiao Li，MD | user2@example.com | None | 2024-06-01 | 2024-12-30 | 2025-12-30 | - | - | 2025-07-14 |
| Risk Factors and Deep Learning Model for CI-AKI | NCT06596785 | Xiao Li，MD | user2@example.com | None | 2024-06-01 | 2025-06-01 | 2026-06-01 | - | - | 2025-07-14 |